Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles (2018 - 2020)
Xenon Pharmaceuticals' (XENE) quarterly Amortizatization of Intangibles came in at $79000.0 in Q2 2020, down 39.23% year-on-year from $130000.0 in Q3 2019, and down 42.34% on a QoQ basis from $137000.0 in Q1 2020.
Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles (2018 - 2020) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 3 years of Amortizatization of Intangibles data on file, last reported at $79000.0 in Q2 2020.
- On a quarterly basis, Amortizatization of Intangibles fell 39.23% year-over-year to $79000.0 in Q2 2020; TTM through Dec 2020 was $216000.0, a 58.86% decrease from a year earlier, with the FY2020 full-year figure at $216000.0, down 58.86% from the prior year.
- Amortizatization of Intangibles for Q2 2020 stood at $79000.0, down from $137000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for XENE reached as high as $137000.0 in Q4 2019 and fell as low as -$8000.0 in Q3 2018.
- Historically, Amortizatization of Intangibles has averaged $102500.0 across 3 years, with a median of $126500.0 in 2018.
- Across the five-year window, Amortizatization of Intangibles soared 1762.5% in 2019 and slumped 39.23% in 2020, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $128000.0 in 2018, then advanced by 7.03% to $137000.0 in 2019, then sank by 42.34% to $79000.0 in 2020.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $79000.0 in Q2 2020, $137000.0 in Q1 2020, and $137000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Xenon Pharmaceuticals | 5.75 Bn | 5.75 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 79,000.00 |
| Jun 30, 2020 | 79,000.00 |
| Mar 31, 2020 | 137,000.00 |
| Mar 31, 2020 | 137,000.00 |
| Dec 31, 2019 | 137,000.00 |
| Dec 31, 2019 | 137,000.00 |
| Sep 30, 2019 | 133,000.00 |
| Sep 30, 2019 | 133,000.00 |
| Jun 30, 2019 | 130,000.00 |
| Jun 30, 2019 | 130,000.00 |
| Mar 31, 2019 | 125,000.00 |
| Mar 31, 2019 | 125,000.00 |
| Dec 31, 2018 | 128,000.00 |
| Dec 31, 2018 | 128,000.00 |
| Sep 30, 2018 | -8,000.00 |
| Sep 30, 2018 | -8,000.00 |
| Jun 30, 2018 | 92,000.00 |
| Jun 30, 2018 | 92,000.00 |
| Mar 31, 2018 | 72,000.00 |
| Mar 31, 2018 | 72,000.00 |